Liping Deng
Wuhan University
35 Papers
159 Citations
Liping Deng is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 27 publications.
Chat about Author
Papers
The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
TL;DR: Wang et al. as mentioned in this paper compared the prevalence of dyslipidemia and risk factors associated with lipid levels in a cohort of HIV-infected patients receiving two different antiretroviral therapy (ART) regimens, nucleoside reverse transcriptase inhibitor/non-nucleoside Reverse Transformer inhibitor (NRTI/NNRTI) and nucleosideside reverse RNA strand transfer inhibitor (INI/INSTI).
5
Characteristics of Peripheral Lymphocyte Subset Alteration in 2019-nCoV Pneumonia
Fan Wang,Jiayan Nie,Hongling Wang,Yu Xiao,Haizhou Wang,Xiao-Ping Liu,Liping Deng,Yuanyuan Xing,Tielong Chen,Xiaoping Chen,Shihui Song,Zhenshun Cheng,Junli Fan,Hengning Ke,Shicheng Gao,Jin Li,Min Chen,Liping Chen,Ying Chang,Rui Zhou,Jun Fang,Jing Liu,Xiaobing Wang,Fei Xu,Xing Huang,Peng-Fei Chen,Guozhen Li,Jun Lin,Xinghuan Wang,Qiu Zhao,Yong Xiong,Pingzheng Mo,Yongxi Zhang +32 more
TL;DR: Peripheral lymphocyte subset alteration demonstrated a significant association with the clinical characteristics and efficacy of NCP, and tended to be an independent predictor for NCP severity and treatment efficacy.
4
Rapid Progression of Kaposi’s sarcoma complicated with hemophagocytic syndrome in a severely immunosuppressed patient with HIV-infection: a case report
TL;DR: A rare case of rapid progression of Kaposi’s sarcoma complicated with hemophagocytic syndrome in a severely immunosuppressed patient with HIV-infection, which was life-threatening and chemotherapy initiated in a timely manner might improve prognosis.
The safety and efficacy of PD-1 inhibitors in patients with advanced cancers and HIV/AIDS in China
Pingzheng Mo,Yajun Yan,Zhuang Ke,Zhiyong Ma,Xiaoping Chen,Liping Deng,Di Deng,Yongxi Zhang +7 more
TL;DR: This study demonstrates that camrelizumab treatment in patients with advanced cancers and HIV/AIDS was feasible and the clinical outcomes were acceptable.
3
[Clinicpathological features and survival of patients with AIDS related non-Hodgkin's lymphoma].
TL;DR: ARL is more common in young adults; one-year mortality rate is high; anti-HIV therapy combined with anti-NHL therapy could significantly improve the prognosis of ARL patients.
2